Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Shingles Vaccine Market , by Region, 2019-2027 (USD Billion)
1.2.2. Shingles Vaccine Market , by Product, 2019-2027 (USD Billion)
1.2.3. Shingles Vaccine Market , by Type, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Shingles Vaccine Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Shingles Vaccine Market Dynamics
3.1. Shingles Vaccine Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing risk of developing shingles
3.1.1.2. Cost-effectiveness of vaccination
3.1.2. Market Restraint
3.1.2.1. Low awareness regarding shingles
3.1.2.2. Weak product pipeline
3.1.3. Market Opportunities
3.1.3.1. Increase in the recommendation of shingles vaccination
Chapter 4. Global Shingles Vaccine Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Shingles Vaccine Market , by Product
5.1. Market Snapshot
5.2. Global Shingles Vaccine Market by Product, Performance - Potential Analysis
5.3. Global Shingles Vaccine Market Estimates & Forecasts by Product 2018-2027 (USD Billion)
5.4. Shingles Vaccine Market , Sub Segment Analysis
5.4.1. Shingrix
5.4.2. Zostavax
5.4.3. SKYZoster
Chapter 6. Global Shingles Vaccine Market , by Type
a. Market Snapshot
6.1. Global Shingles Vaccine Market by Type, Performance - Potential Analysis
6.2. Global Shingles Vaccine Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
6.3. Shingles Vaccine Market , Sub Segment Analysis
6.3.1. Recombinant vaccine
6.3.2. Live attenuated Vaccine
Chapter 7. Global Shingles Vaccine Market , Regional Analysis
7.1. Shingles Vaccine Market , Regional Market Snapshot
7.2. North America Shingles Vaccine Market
7.2.1. U.S. Shingles Vaccine Market
7.2.1.1. Product breakdown estimates & forecasts, 2018-2027
7.2.1.2. Type breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Shingles Vaccine Market
7.3. Europe Shingles Vaccine Market Snapshot
7.3.1. U.K. Shingles Vaccine Market
7.3.2. Germany Shingles Vaccine Market
7.3.3. France Shingles Vaccine Market
7.3.4. Spain Shingles Vaccine Market
7.3.5. Italy Shingles Vaccine Market
7.3.6. Rest of Europe Shingles Vaccine Market
7.4. Asia-Pacific Shingles Vaccine Market Snapshot
7.4.1. China Shingles Vaccine Market
7.4.2. India Shingles Vaccine Market
7.4.3. Japan Shingles Vaccine Market
7.4.4. Australia Shingles Vaccine Market
7.4.5. South Korea Shingles Vaccine Market
7.4.6. Rest of Asia Pacific Shingles Vaccine Market
7.5. Latin America Shingles Vaccine Market Snapshot
7.5.1. Brazil Shingles Vaccine Market
7.5.2. Mexico Shingles Vaccine Market
7.6. Rest of The World Shingles Vaccine Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. GlaxoSmithKline plc.
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Merck & Co., Inc.
8.2.3. SK chemicals
8.2.4. Green cross corp.
8.2.5. CanSinoBIO
8.2.6. Geneone Life Science
8.2.7. Vaccitech
8.2.8. Precision Vax LLC
8.2.9. Inovio Pharmaceuticals, Inc.
8.2.10. Sanofi

Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption